<DOC>
	<DOCNO>NCT01817543</DOCNO>
	<brief_summary>The aim trial demonstrate effectiveness complete wound heal prospective , open-label , cohort-controlled trial venous leg ulcer ( VLU ) n treat use AutoloGel case-matched concurrent cohort patient receive undefined Usual Customary Care ( UCC )</brief_summary>
	<brief_title>A Cohort Trial Comparing AutoloGel Therapy Usual Customary Care Venous Leg Ulcers</brief_title>
	<detailed_description>Recurrence ulcer leg common ; two-thirds patient likely experience recur ulcer first ulcer . While treatment underlie venous disease , depend mode treatment , low recurrence rate many patient , affect recurrence . AutoloGel platelet-rich plasma ( PRP ) gel use treatment non-healing chronic wound . The aim trial demonstrate effectiveness , measure complete wound healing , prospective , open-label trial venous leg ulcer treat use AutoloGel standard care case-matched concurrent cohort patient receive undefined Usual Customary Care</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>1 . Medicare/Medicaid eligible 2 . ≥18 year age 3 . Proven venous disease 4 . The large nonhealing wound , multiple wound present , single wound treat ( Index Ulcer ) locate include knee ankle 5 . For subject potentially multiple eligible VLUs , large ulcer select . There must least 4 cm Index Ulcer ulcer ; ulcer closer 4 cm , subject enrol ( screen failure ) 6 . Debrided ulcer size 2 cm2 200 cm2 7 . Demonstrated adequate compression regimen 8 . Duration ≥ 1 month first visit 9 . Subject must willing comply Protocol , assess enrol clinician . 1 . Subjects know sensitive AutoloGel component ( calcium chloride , thrombin , ascorbic acid ) and/or material bovine origin 2 . Presence another wound concurrently treat might interfere treatment index wind AutoloGel 3 . Ulcer VLU pathophysiology ( e.g. , pure diabetic , vasculitic , radiation , rheumatoid , collagen vascular disease , pressure , arterial etiology ) 4 . Any malignancy nonmelanoma skin cancer 5 . Subjects cognitively impair healthcare proxy 6 . Serum albumin less 2.5 g/dL 7 . Plasma Platelet count le 100 x 109/L 8 . Hemoglobin le 10.5 g/dL 9 . Subject inadequate venous access repeat blood draw require AutoloGel Administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>venous leg ulcer</keyword>
	<keyword>non heal wound</keyword>
</DOC>